Literature DB >> 11237557

Prostaglandin J(2) inhibition of mesangial cell iNOS expression.

C M Reilly1, J C Oates, J Sudian, M B Crosby, P V Halushka, G S Gilkeson.   

Abstract

Mesangial cells from MRL/lpr mice, a model of lupus, overproduce nitric oxide (NO) compared to controls. J series prostaglandins (PG) and thiazolidinediones block LPS stimulation of NO production via the activation of peroxisome proliferator-activator receptor-gamma (PPAR-gamma) in macrophages but utilize an alternative mechanism in microglial cells. We investigated the mechanism by which PGJ(2) inhibits NO production in LPS/IFN-gamma-stimulated MRL/lpr mesangial cells. Our results demonstrated that LPS/IFN-gamma addition to MRL/lpr mesangial cells stimulated iNOS activation, expression of p-38 kinase and p44/42 MAPK, and NF-kappaB translocation to the nucleus. Both pioglitazone, a specific PPAR-gamma agonist, and PGJ(2) blocked NO production, iNOS protein expression, and iNOS mRNA transcription. PGJ(2) failed to inhibit nuclear NF-kappaB translocation or p44/42 MAPK or p-38 kinase induction in stimulated mesangial cells. These data suggest that PGJ(2) blocks iNOS expression and subsequent NO production in mesangial cells via a PPAR-gamma-mediated mechanism either by interfering with NF-kappaB transcriptional activity or by an NF-kappaB-independent mechanism. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237557     DOI: 10.1006/clim.2000.4985

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

Review 1.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity.

Authors:  Kailin Yan; Qiang Cao; Christopher M Reilly; Nicolas L Young; Benjamin A Garcia; Nilamadhab Mishra
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

3.  Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells.

Authors:  Abigail Peairs; Rujuan Dai; Lu Gan; Samuel Shimp; M Nichole Rylander; Liwu Li; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2010-02-08       Impact factor: 11.530

4.  Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.

Authors:  Samuel K Shimp; Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Molly A Read; David L Caudell; Marissanichole Rylander; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2012-04-30       Impact factor: 11.530

Review 5.  The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus.

Authors:  Jim C Oates; Gary S Gilkeson
Journal:  Clin Immunol       Date:  2006-07-24       Impact factor: 3.969

6.  Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Authors:  Salvatore Cuzzocrea; Barbara Pisano; Laura Dugo; Angela Ianaro; Nimesh S A Patel; Rosanna Di Paola; Tiziana Genovese; Prabal K Chatterjee; Massimo Di Rosa; Achille P Caputi; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

7.  Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells.

Authors:  A Peairs; A Radjavi; S Davis; L Li; A Ahmed; S Giri; C M Reilly
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

8.  Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy.

Authors:  Eugenia Hovsepian; Federico Penas; Gerardo A Mirkin; Nora B Goren
Journal:  PPAR Res       Date:  2012-02-09       Impact factor: 4.964

9.  Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.

Authors:  Undurti N Das
Journal:  J Inflamm Res       Date:  2010-12-02

10.  15-Deoxy-Delta-Prostaglandin J(2) Upregulates the Expression of LPS-Induced IL-8/CXCL8 mRNA in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats.

Authors:  Jung Hae Kim; Hee Sun Kim
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.